• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT180
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 08/08/2022
Event Type  Death  
Manufacturer Narrative
Since the literature described "gif uct180", olympus selected "gf-uct180" as a representative product.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "eus-guided biliary drainage in patients with moderate¿severe cholangitis is safe and effective: a multi-center experience." this is a retrospective review of a prospectively maintained endoscopy database to assess outcomes of endoscopic ultrasound-guided biliary drainage (eus-bd) in patients with moderate¿severe cholangitis.A total of 263 cases of eus-bd were reviewed.Of the 49 patients (23 male; 46.9%) presenting with moderate/severe cholangitis, 23 (46.9%) had severe cholangitis.Clinical success with improvement of cholangitis, on the overall cohort, was 91.7% (44/48).Effective biliary drainage (ebd) defined as reduction in bilirubin by more than 50% of baseline at 2 weeks, and/or bilirubin<3.0 mg/dl at 4 weeks.Ebd, on the overall cohort, was noted in 85.4% (41/48) cases.Adverse events in the form of mostly bleeding and bile leak were noted in 5 cases (10.2%) but managed conservatively.Distal obstruction exhibited significantly better clinical success (100% vs.78.9%; p=0.02) than hilar obstruction.In conclusion, in case of failed/non-feasible ercp, eus-bd can be a safe and an effective alternative option for patients with moderate to severe cholangitis, even with significant pre-morbid conditions, with acceptable adverse events rate.Type of adverse events/number of patients: bleeding : 1 patient.Intrahepatic cholestasis : 1 patient.Hemobilia : 2 patients.Bile leak :1 patient.Death 2 days after procedure due to massive pulmonary embolism : 1 patient.Death 3 months after procedure : 10 patient.This literature article requires 2 reports.The related patient identifiers are as follows: (b)(6): for adverse events.(b)(6): for patient death.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE
Type of Device
ULTRASOUND GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA   961-8061
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16659067
MDR Text Key312489156
Report Number3002808148-2023-03212
Device Sequence Number1
Product Code ODG
UDI-Device Identifier04953170356339
UDI-Public04953170356339
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K093395
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/31/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGF-UCT180
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-